Free Access to Live Webinars
Get a Snapshot of Critical Industry Issues
Accurate and Reproducible Inline Dilution with Process Scale Chromatography SkidsSébastien Lefebvre, Hardware Sales Support Manager, Process Chromatography Division, Bio-Rad Laboratories June 12, 2012 |
|
Next-Generation Sequencing at Genomic Health: New Opportunities for DiagnosticsJoffre Baker, Chief Scientific Officer, Genomic Health Inc. Recorded on April 3, 2012 |
|
A New Vision for the Drug-Diagnostic Value Paradigm: Bringing Personalized Medicine to MarketPaul Bereford, Ph.D., Vice President, Business Development and Strategic Marketing, Biodesix Recorded on April 10, 2012 |
|
Circulating Tumors Cells as Biomarkers: Opportunities for Non-invasive Tumor Characterization and Patient Stratification in OncologyYvon Cayre, Ph.D., Professor, Department of Clinical Hematology, Hôpital Robert Debré Recorded on April 24, 2012 |
|
Noninvasive Sequencing of Fetal DNACharles Cantor, Ph.D., Chief Scientific Officer, Sequenom, Inc. Recorded on May 22, 2012 |
August 6-8, 2012 · Westin San Francisco Market Street · San Francisco, CA
A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences: